MUMBAI, India--(BUSINESS WIRE)--GVK Biosciences (GVK BIO), Asia’s leading Discovery Research and Development organization today unveiled a new brand CLINOGENT in the Clinical Development industry. CLINOGENT provides end to end Clinical Development services. From offering bioequivalence studies for generic pharma and late phase patient based clinical studies for research based companies, CLINOGENT brings exceptional expertise in delivering solutions to complex data analysis and medical communication problems to customers the world over. CLINOGENT will endeavor to provide innovative solutions to all the Clinical and scientific challenges that their customers face in the business.
Help employers find you! Check out all the jobs and post your resume.
